GE Healthcare Technologies (GEHC) stock
Last close $81.89 on 2026-11-19 (-2.12%) · Sector: Healthcare
GE HealthCare Technologies (NYSE: GE) makes medical technology used in hospitals and clinics, including imaging scanners, ultrasound, patient monitoring, and related software and services. It earns money mainly by selling this equipment and by providing servicing, parts, and support contracts after the sale.
GE HealthCare is growing its revenue at 6.8% a year and remains profitable, with an operating margin of 13.4%. Over the past year the stock returned 9.6%, roughly in line with the S&P 500 at 9.7%, though it did not beat the market. The shares are 8.8% below their 52-week high and trade above both their 50-day and 200-day averages. The stock often moves sharply after earnings reports, falling 13.2% after one in April 2026 and rising 12.2% after one in July 2026, and directors bought shares in May 2026 while no insider sales were recorded.
Key numbers
- Market cap: $37.1B
- Revenue (last 12 months): $21.63B
- Revenue growth: +6.8%
- Gross margin: 39.9%
- Operating margin: 13.4%
- P/E: 17.3
- P/S: 1.7
- Debt to equity: 0.86
- Current ratio: 1.30
Quality score
Overall 39/100 · growth 35 · profitability 36 · financial health 36 · value 48
Performance and risk
1-year return +9.6% vs S&P 500 +9.7% · volatility 35.7% (S&P 500 13.8%) · largest drop -32.5% · beta 0.67
Stock move the day after earnings
- 2026-02-04: +4.9%
- 2026-04-29: -13.2%
- 2026-07-23: -2.3%
- 2026-07-29: +12.2%
- 2026-10-28: +6.6%
Insider trades (12 months)
Bought $6.5M · sold $0.0M
GEHC stock research · GEHC options calculator · Stocks to buy, hold or sell today
StrikeWright provides AI signals only, not financial advice.